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Background: Symptomatic Atrial Fibrillation (AF) poses a significant burden on physical health, mental health and quality of life (QoL) and 
can potentially affect family members also. Radiofrequency ablation (RFA)has evolved into main stream therapy for AF. Effect of RFA on anxiety, 
depression and QoL scores in patients and family members have not been previously studied.
Methods: In a prospective observational study, all patients undergoing pulmonary vein isolation (PVI) for symptomatic AF were identified between 
June 2008 and June 2009. Subjects and their significant others were invited to participate through mail. Short Form 36 (SF-36), Zung self-rated 
anxiety (SAS) and Zung Self-rated Depression Scales (SDS) were used to assess QoL and psychological screening scores in patients and significant 
others before anticipated PVI, at 3 months and 6 months after PVI.
Results: A total of 97 patients (mean age 61±10yrs, male 67%, Caucasians 95%) completed the pre-procedural questionnaires. The follow-up mail 
return rates were 62 and 45 at 3 and 6 months for patients. Number of spouses responded were 85 at baseline, 54 at 3 months, and 30 and at 
6 months. 59 (61%) had paroxysmal, 29 (30%) had persistent and 9 (9%) had permanent AF with a mean duration of 66±67 months. AF recurred 
in 26 (27%) by 6 months. Patients had scores of (39±9, 36±9, 34±9) on SDS, (38±6, 37±6, 36±5) on SAS and (59±20, 66±24, 70±22) on SF-36 
scales at baseline, 3 and 6 months after RFA respectively. Significant others had scores of (36±9, 36±8, 35±10) on SDS, (36±6, 35±6, 34±7) on 
SAS and (77±17, 78±14, 79±15) on SF-36 scores respectively. Significant improvement was seen in SDS and SAS scores only in patientsat 6 months 
(p=0.01) and significant other’s SF-36 scores at 3 and 6 months after RFA (p=0.03 ). A repeated measures one-way ANOVA showed significant 
differences in SF-36 scores amongst the 3 measurements, in patients (F (1.6) = 8.7, p =.007) as wells as significant others (F (1.6) =50, p<0.001).
Conclusion: PVI significantly improves QoL scores in both patients and their spouses. Depression and anxiety scores are significantly better after 
successful sinus rhythm restoration only in patients after RFA.
